RecruitingPhase 2NCT05076942
Groningen International Study on Sentinel Nodes in Vulvar Cancer-III
Studying Vulvar carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Medical Center Groningen
- Intervention
- Radiotherapy combined with cisplatin(radiation)
- Enrollment
- 157 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2021 – 2029
Study locations (27)
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States
- Mount Sinai Medical Center, Miami Beach, Florida, United States
- Baystate Medical Center, Springfield, Massachusetts, United States
- Spectrum Health at Butterworth Campus, Grand Rapids, Michigan, United States
- Munson Medical Center, Traverse City, Michigan, United States
- Nebraska Methodist Hospital, Omaha, Nebraska, United States
- Women's Cancer Center of Nevada, Las Vegas, Nevada, United States
- Memorial Sloan Kettering Basking Ridge, Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen, Montvale, New Jersey, United States
- Memorial Sloan Kettering Commack, Commack, New York, United States
- Memorial Sloan Kettering Westchester, Harrison, New York, United States
- Memorial Sloan Kettering Cancer Center, New York, New York, United States
- Memorial Sloan Kettering Nassau, Uniondale, New York, United States
- Duke University Medical Center, Durham, North Carolina, United States
- +12 more locations on ClinicalTrials.gov
Collaborators
Dutch Cancer Society · NRG Oncology
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05076942 on ClinicalTrials.govOther trials for Vulvar carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT06447064Cancer Loyalty Card Study 2 (CLOCS-2)Imperial College London
- RECRUITINGNCT07380698The Effect of Dose and Storage Conditions of Indocyanine Green on Efficacy and Cost in Sentinel Lymph Node Mapping in Gynecological CancerCukurova University
- ENROLLING BY INVITATIONNANCT07023601International Prospective Multicentre Study That Evaluate the Sentinel Lymph Node Detection Rate in Patients With First Local Recurrent Scamous Cell Carcinoma of the Vulva.Hospital Universitario La Paz
- RECRUITINGPHASE2NCT05903833Pembrolizumab Combination With Lenvatinib in Pts With Recurrent,Persistent,Metastatic or Locally Advanced Vulvar Cancer Not Amenable to Curative Surgery or RadiotherapyAGO Research GmbH
- RECRUITINGNANCT05576831STRatIfication of Vulvar Squamous Cell Carcinoma by HPV and p53 Status to Guide ExcisionBritish Columbia Cancer Agency
- RECRUITINGNANCT06495554Danish Vulva Cancer Recurrence StudyUniversity of Aarhus
- RECRUITINGNANCT06264167NODE (groiN ultrasOunD cancEr)Queensland Centre for Gynaecological Cancer
- ACTIVE NOT RECRUITINGNANCT06694116Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar CancerIstanbul University